Patents Assigned to Centogene GmbH
  • Method for the diagnosis of Niemann-Pick disease
    Patent number: 11841362
    Abstract: The present invention is related to a method for diagnosing Niemann-Pick disease in a subject comprising a step a), wherein the step a) comprises detecting a biomarker in a sample from the subject.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: December 12, 2023
    Assignee: Centogene GmbH
    Inventors: Arndt Rolfs, Hermann Mascher
  • Method for the diagnosis of Niemann-Pick disease
    Patent number: 11231412
    Abstract: The present invention is related to a method for diagnosing Niemann-Pick disease in a subject comprising a step a), wherein the step a) comprises detecting a biomarker in a sample from the subject.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: January 25, 2022
    Assignee: Centogene GmbH
    Inventors: Arndt Rolfs, Hermann Mascher
  • Method for the diagnosis of Farber's disease
    Patent number: 11204357
    Abstract: The present invention is related to a method for diagnosing Farber's disease in a subject, wherein the method comprises detecting C26 ceramide in a sample from the subject.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: December 21, 2021
    Assignee: Centogene GmbH
    Inventors: Arndt Rolfs, Claudia Cozma
  • Use of lyso-Gb1 as druggable target
    Patent number: 11097016
    Abstract: The present invention is related to the in vitro use of lyso-Gb1 as a draggable target in the development of a drug, and to antagonist of lyso-Gb1 for use in the treatment and/or prevention of a disease, wherein the disease is Gaucher disease or Parkinson's disease.
    Type: Grant
    Filed: July 3, 2017
    Date of Patent: August 24, 2021
    Assignee: Centogene GmbH
    Inventors: Claudia Cozma, Peter Bauer
  • Method for the diagnosis of Gaucher's disease
    Patent number: 11092609
    Abstract: The present invention is related to an in vitro method for diagnosing Gaucher's disease in a subject comprising a step of a) detecting a biomarker in a sample from the subject, wherein the biomarker is free lyso-Gb1.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: August 17, 2021
    Assignee: Centogene GmbH
    Inventors: Arndt Rolfs, Hermann Mascher
  • Method for the diagnosis of Gaucher's disease
    Patent number: 10859580
    Abstract: The present invention is related to an in vitro method for diagnosing Gaucher's disease in a subject comprising a step of a) detecting a biomarker in a sample from the subject, wherein the biomarker is free lyso-Gb1.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: December 8, 2020
    Assignee: Centogene GmbH
    Inventors: Arndt Rolfs, Hermann Mascher